Subsets of acral melanoma patients harbour amplifications of PAK1 (22% of tumours) and YAP1 (12% of tumours) loci [123], suggesting a dependency on these pathways for proliferation and/or invasion. The gene discussed is PAK1; the disease is acral lentiginous melanoma.